# FDA recall D-1413-2020

> **Lupin Pharmaceuticals Inc.** · Class II · drug recall initiated 2020-07-17.

## Product

Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08

## Reason for recall

Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg

## Distribution

Product was distributed to OH and may have been further distributed throughout the United States.

## Key facts

- **Recall number:** D-1413-2020
- **Recalling firm:** Lupin Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-07-17
- **Report date:** 2020-08-05
- **Termination date:** 2021-08-26

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Baltimore, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1413-2020

## Citation

> AI Analytics. FDA recall D-1413-2020. Retrieved 2026-07-13 from https://api.ai-analytics.org/recall/D-1413-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*